These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34876789)

  • 1. Hemostasis testing in patients with liver dysfunction: Advantages and caveats.
    Nguyen G; Lejeune M; Crichi B; Frere C
    World J Gastroenterol; 2021 Nov; 27(42):7285-7298. PubMed ID: 34876789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viscoelastic tests in liver disease: where do we stand now?
    Buliarca A; Horhat A; Mocan T; Craciun R; Procopet B; Sparchez Z
    World J Gastroenterol; 2021 Jun; 27(23):3290-3302. PubMed ID: 34163112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation pattern in critical liver dysfunction.
    Schaden E; Saner FH; Goerlinger K
    Curr Opin Crit Care; 2013 Apr; 19(2):142-8. PubMed ID: 23400090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease.
    Janko N; Majeed A; Kemp W; Roberts SK
    Semin Thromb Hemost; 2020 Sep; 46(6):704-715. PubMed ID: 32932542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscoelastic Testing in Liver Disease.
    Davis JPE; Northup PG; Caldwell SH; Intagliata NM
    Ann Hepatol; 2018 Mar; 17(2):205-213. PubMed ID: 29469043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.
    Lisman T; Hernandez-Gea V; Magnusson M; Roberts L; Stanworth S; Thachil J; Tripodi A
    J Thromb Haemost; 2021 Apr; 19(4):1116-1122. PubMed ID: 33792172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis in liver disease: implications of new concepts for perioperative management.
    Weeder PD; Porte RJ; Lisman T
    Transfus Med Rev; 2014 Jul; 28(3):107-13. PubMed ID: 24721432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either-or Proposition.
    Bunch CM; Berquist M; Ansari A; McCoy ML; Langford JH; Brenner TJ; Aboukhaled M; Thomas SJ; Peck E; Patel S; Cancel E; Al-Fadhl MD; Zackariya N; Thomas AV; Aversa JG; Greene RB; Seder CW; Speybroeck J; Miller JB; Kwaan HC; Walsh MM
    Semin Thromb Hemost; 2022 Oct; 48(7):769-784. PubMed ID: 36174601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosurgical applications of viscoelastic hemostatic assays.
    Kvint S; Schuster J; Kumar MA
    Neurosurg Focus; 2017 Nov; 43(5):E9. PubMed ID: 29088950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy.
    Müller MC; Straat M; Meijers JC; Klinkspoor JH; de Jonge E; Arbous MS; Schultz MJ; Vroom MB; Juffermans NP
    J Thromb Haemost; 2015 Jun; 13(6):989-97. PubMed ID: 25809519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.
    Lisman T; Porte RJ
    Blood; 2010 Aug; 116(6):878-85. PubMed ID: 20400681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review.
    Lange NW; Salerno DM; Berger K; Cushing MM; Brown RS
    J Intensive Care Med; 2021 May; 36(5):524-541. PubMed ID: 32079443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver disease, coagulation testing, and hemostasis.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):265-82. PubMed ID: 19665678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease.
    DeAngelis GA; Khot R; Haskal ZJ; Maitland HS; Northup PG; Shah NL; Caldwell SH
    J Vasc Interv Radiol; 2016 Nov; 27(11):1665-1674. PubMed ID: 27595469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation.
    Mallett SV
    Semin Thromb Hemost; 2015 Jul; 41(5):527-37. PubMed ID: 26049072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Coagulation Testing in Acute Care Medicine: Back to Bedside?
    Caspers M; Holle JF; Limper U; Fröhlich M; Bouillon B
    Hamostaseologie; 2022 Dec; 42(6):400-408. PubMed ID: 36549292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.
    Lisman T; Leebeek FW
    Dig Surg; 2007; 24(4):250-8. PubMed ID: 17657149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.